BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34665427)

  • 21. The Prognosis of Papillary Thyroid Cancer with Initial Distant Metastasis is Strongly Associated with Extensive Extrathyroidal Extension: A Retrospective Cohort Study.
    Lee YK; Kim D; Shin DY; Lee CR; Lee EJ; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Park CS
    Ann Surg Oncol; 2019 Jul; 26(7):2200-2209. PubMed ID: 30895495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
    Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
    Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive Value of a Prognostic Model Based on Lymphocyte-to-Monocyte Ratio Before Radioiodine Therapy for Recurrence of Papillary Thyroid Carcinoma.
    Zhou C; Duan D; Liu S
    Technol Cancer Res Treat; 2021; 20():15330338211027910. PubMed ID: 34191658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papillary thyroid cancer: factors involved in restaging N1 disease after total thyroidectomy and radioactive iodine treatment.
    Guy A; Hirsch D; Shohat T; Bachar G; Tirosh A; Robenshtok E; Shimon I; Benbassat CA
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4167-73. PubMed ID: 25157544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
    Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
    J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
    Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
    J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Ince S; Arslan N
    Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
    Forleo R; Grani G; Alfò M; Zilioli V; Giubbini R; Zatelli MC; Gagliardi I; Piovesan A; Ragni A; Morelli S; Puxeddu E; Pagano L; Deandrea M; Ceresini G; Torlontano M; Puligheddu B; Antonelli A; Centanni M; Fugazzola L; Spiazzi G; Monti S; Rossetto R; Monzani F; Tallini G; Crescenzi A; Sparano C; Bruno R; Repaci A; Tumino D; Pezzullo L; Lombardi CP; Ferraro Petrillo U; Filetti S; Durante C; Castagna MG
    Thyroid; 2021 Dec; 31(12):1814-1821. PubMed ID: 34541894
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
    Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
    J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocytochemical characteristics of thyrocytes in radioiodine refractory metastases of papillary thyroid cancer.
    Zelinskaya A
    Exp Oncol; 2019 Dec; 41(4):342-345. PubMed ID: 31868336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
    Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
    Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
    Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features.
    Suman P; Razdan SN; Wang CE; Tulchinsky M; Ahmed L; Prinz RA; Winchester DJ
    J Am Coll Surg; 2020 Jan; 230(1):136-144. PubMed ID: 31672668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.
    Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY
    Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrabony mandibular metastases caused by papillary thyroid carcinoma masquerading as a parotid swelling.
    Wareing J; Dawoud B; Power A; Sutton D
    Ann R Coll Surg Engl; 2021 Sep; 103(8):e264-e265. PubMed ID: 34464554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Outcomes and Prognoses of Elderly Patients (≥65-Years-Old) With Distant Metastases From Well-Differentiated Thyroid Cancer During Radioiodine Therapy and Follow-Up.
    Qiu ZL; Shen CT; Sun ZK; Song HJ; Xi C; Zhang GQ; Wang Y; Luo QY
    Front Endocrinol (Lausanne); 2020; 11():588024. PubMed ID: 33716950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.